Diagnostic methodologies for chlamydia screening in females aged 15 to 25 years from private insurance claims data in the United States, 2001 to 2005.
Owusu-Edusei
Kwame
K
Division of STD Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road MS E-80, Atlanta, GA, USA. Kowusuedusei@cdc.gov
Bohm
Michele K
MK
Kent
Charlotte K
CK
D000293:Adolescent; D000328:Adult; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology; D002692:Chlamydia trachomatis / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D003470:Culture Media; D016208:Databases, Factual / Q000706:statistics & numerical data*; D005260:Female; D005455:Fluorescent Antibody Technique; D006264:Health Benefit Plans, Employee / Q000706:statistics & numerical data*; D006801:Humans; D007124:Immunoenzyme Techniques; D008403:Mass Screening / Q000379:methods* / Q000706:statistics & numerical data*; D021141:Nucleic Acid Amplification Techniques; D014481:United States / Q000453:epidemiology; D055815:Young Adult
D003470:Culture Media